Plasma and hepatic tissue levels of thrombomodulin, tissue factor, NFκB and nitric oxide in responders and nonresponders to IFNα therapy

Journal of Viral Hepatitis

Volumn 10, Issue 5, 2003, Pages 360-366

  George, M ^a   Baluch, M ^a   Van Thiel, D H ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatitis C virus; Interferon ; NF B; Nitric oxide; Thrombomodulin; Tissue factor

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; THROMBOMODULIN; THROMBOPLASTIN; UROKINASE;

ADULT; ARTICLE; CELL ASSAY; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; DATA ANALYSIS; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; MALE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIOPSY; CELL NUCLEUS; CYTOSOL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE; THROMBOMODULIN; THROMBOPLASTIN; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0141650733     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00431.x     Document Type: Article

References (33)

1. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-113.
2. Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi MR, Pedrazzini E, Bonatti S, Migliaccio G. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 2002; 292: 31-43.
3. De Francesco R, Neddermann P, Tomei L, Steinkuhler C, Gallinari P, Folgori A. Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines. Semin Liver Dis 2000; 20: 69-83.
4. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000; 243: 55-84.
5. Tai DI, Tsai SL, Chen YM, Chuang YL, Pens CY, Sheen IS, Yeh CT, Chang KSS, Huang SN, Kuo GC, Liaw YF. Activation of nuclear factor κB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000; 31: 656-664.
6. Vendenmaile G, Grattagliano I, Portincasa P, Serviddio G, Palasciamo G, Altomare E. Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up. Eur J Clin Invest 2001; 31: 54-63.
7. Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 2001; 34: 587-592.
8. Shivastava A, Manna SK, Ray R, Aggarwal BB. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 1998; 71: 9722-9728.
9. Friedlander L, Van Thiel DH, Faruki H, Molloy PJ, Kania RJ, Hassanein T. New approach to HCV treatment recognition of disease process as systemic viral infection rather than as liver disease. Dig Dis Sci 1996; 41: 1678-1681.
10. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746.
11. Himmelreich G, Riewald M, Rosch R, Blumhard G, Neuhaus P, Roissant R, Riess H. Thrombomodulin: a marker for endothelial damage during orthotopic liver transplantation. Am J Hematol 1994; 47: 1-5.
12. Takatori M, Iwabuchi S, Ro S, Murayama M, Maeyama S, Uchikoshi T, Nakano M, Ishii H. Increased serum levels and sinusoidal expression of thrombomodulin in acute liver damage. Thrombosis Res 1999; 93: 113-120.
13. Leirisalo-Repo M. The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 1994; 75 Suppl 2: 1-3.
14. Chapmann HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-724.
15. Huang S, New L, Pan Z, Han J, Nemerow GR. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. J Biological Chemistry 2000; 275; 12266-12272.
16. Leyland H, Gentry J, Arthur MJP, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatol 1996; 24: 1172-1178.
17. Saksela O, Rifkin DB. Cell-associated activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93-126.
18. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992; 667: 1-12.
19. Moncada S, Palmer RM, Higgs EA. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
20. Palmer RM, Rerriga AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 327: 524-526.
21. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to Interferon therapy is influenced by the iron content of the liver. J Hepatol 1994; 20: 410-415.
22. Van Thiel DH, Friedlander L, Wright HI, Gurakar A, Fagiuoli S, Gavaler JS, Irish W. Gamma-glutamyl transpeptidase as a response preictor when using alpha interferon to treat hepatitis C. Hepato-Gastroenterol 1995; 42: 888-892.
23. Hadziyannis SJ. Use of α interferon in the treatment of chronic hepatitis. J Hepatol 1991; 13: S21-S61.
24. Gaweco AS, Wiesner RH, Porayko M, Rustgi VK, Yong S, Hamdana R, Harig J, Chejfec G, McClatchey KD, Van Thiel DH. Intragraff localization of activated nuclear factor κB in recurrent hepatitis C virus disease following liver transplantation. Hepatology 2000; 31: 1183-1191.
25. Mosialos G. The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcription. Semin Cancer Biol 1997; 8: 121-129.
26. Baldwin ASJ. The NF-κB and bob proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
27. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071
28. You LR, Chen CM, Lee YHM. Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor alpha. J Virol 1999; 281: 1680-1683.
29. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J Virol 1999; 73: 4713-4720.
30. Nemerson Y. Tissue factor and hemostasis. Blood 1998; 71: 1-8.
31. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
32. Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, Ohiwa M, Deguchi K, Shirakawa S. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 1994; 45: 232-236.
33. Kakkur AK, DeRuvo N, Chiswangwatanakul V, Tebbutt S, Williamson RC. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005.